mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0007 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0007 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0007 |
mRNA |
GSK-650394 |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
0.0008 |
mRNA |
etoposide |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.0008 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0009 |
mRNA |
SB590885 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.001 |
mRNA |
IPA-3 |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.001 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |
mRNA |
Doxorubicin |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.001 |